Progress in transcriptionally targeted and regulatable vectors for genetic therapy

Human Gene Therapy

Volumn 8, Issue 7, 1997, Pages 803-815

  Miller, Nicholas ^a,b   Whelan, James ^a,c  

^a GLAXO INST FOR MOLECULAR BIOLOGY   (Switzerland)

^b Arthur Andersen Biotechnology Group   (United Kingdom)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; VIRUS VECTOR;

CANCER; CANCER CELL; CELL TYPE; CHROMATIN; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPRESSOR GENE; REVIEW; SUICIDE GENE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRANSGENE;

EID: 0030996011     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.7-803     Document Type: Review

References (108)

1. ACKLAND-BERGLUND, C.E., and LEIB, D.A. (1995). Efficacy of tetracycline-controlled gene expression is influenced by cell type. BioTechniques 18, 196-200.
2. ADAMS, M.D., KERLAVAGE, A.R., FLEISCHMANN, R.D., FULDNER, R.A., BULT, C.J., LEE, N.H., KIRKNESS, E.F., WEINSTOCK, K.G., GOCAYNE, J.D., and WHITE, O. (1995). Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 377 (Suppl), 3-17.
3. AIRD, W.C., JAHROUDI, N., WEILER-GUETTLER, H., RAYBURN, H.B., and ROSENBERG, R.D. (1995). Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc. Natl. Acad. Sci. USA 92, 4567-4571.
4. ALEXANDER, M.Y., BIDICHANDANI, S.I., COUSINS, F.M., ROBINSON, C.J.M., DUFFIE, E., and AKHURST, R.J. (1995). Circulating human factor IX produced in keratin-promoter transgenic mice: A feasibility study for gene therapy of haemophilia B. Hum. Mol. Genet. 4, 993-999.
5. ARBUTHNOT, P., BRALET, M.-P., THOMASSIN, H., DANAN, J.-L., BRECHOT, C., and FERRY, N. (1995). Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by a-fetoprotein but not insulinlike growth factor II regulatory sequences. Hepatology 22, 1788-1796.
6. ARBUTHNOT, P.B., BRALET, M.-P., LEJOSSIC, C., DEDIEU, J.-F., PERRICAUDET, M., BRECHOT, C., and FERRY, N. (1996). In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum. Gene Ther. 7, 1503-1514.
7. ARNET, U.A., McMILLAN, A., DINERMAN, J.L., BALLERMAN, B., and LOWENSTEIN, C.J. (1996). Regulation of endothelial nitric-oxide synthase during hypoxia. J. Biol. Chem. 271, 15069-15073.
8. BAIM, S.B., LABOW, M.A., LEVINE, A.J., and SHENK, T. (1991). A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl b-D-thiogalactopyranoside. Proc. Natl. Acad. Sci. USA 88, 5072-5076.
9. BARON, U., FREUNDLIEB, S., GOSSEN, M., and BUJARD, H. (1995). Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res. 23, 3605-3606.
10. BILLET, O., GRIMBER, G., LEVRERO, M., SEYE, K.A., BRIAND, P., and JOULIN, V. (1995). In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J. Virol. 69, 5912-5916.
11. BLOCK, K.L., and PONCZ, M. (1995). Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression. Stem Cells 13, 135-145.
12. BOWMAN, B.H., JANSEN, L., YANG, F., ADRIAN, G.S., ZHAO, M., ATHERTON, S.S., BUCHANAN, J.M., GREENE, R., WALTER, C., HERBERT, D.C., WEAKER, F.J., CHIODO, L.K., KAGAN-HALLET, K., and HIXSON, J.E. (1995). Discovery of a brain promoter from the human transferrin gene and its utilisation for development of transgenic mice that express human apolipoprotein E alleles. Proc. Natl. Acad. Sci. USA 92, 12115-12119.
13. BRASELMANN, S., GRANINGER, P., and BUSSLINGER, M. (1993). A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci. USA 90, 1657-1661.
14. CAI, H., and LEVINE, M. (1995). Modulation of enhancer-promoter interactions by insulators in the Drosophila embryo. Nature 376, 533-536.
15. CHARRON, G., GUY, L.-G., BAZINET, M., and JULIEN, J.-P. (1995). Multiple neuron-specific enhancers in the gene coding for the human neurofilament light chain. J. Biol. Chem. 270, 30604-30610.
16. CHEN, L., CHEN, D., MANOME, Y., DONG, Y., FINE, H.A., and KUFE, D.W. (1995). Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J. Clin. Invest. 96, 2775-2782.
17. CHRISTOFFELS, V.M., VAN DEN HOFF, M.J.B., MOORMAN, A.F.M., and LAMERS, W.H. (1995). The far-upstream enhancer of the carbamoyl-phosphate synthetase I gen is responsible for the tissue specificity and hormone inducibility of its expression. J. Biol. Chem. 270, 24932-24940.
18. CONNELLY, S., GARDNER, J.M., MCCLELLAND, A., and KALEKO, M. (1996). High-level tissue-specific expression of functional human factor VIII in mice. Hum. Gene Ther. 7, 183-195.
19. CORIN, S.J., LEVITT, L.K., O'MAHONEY, J.V., JOYA, J.E., HARDEMAN, E.C., and WADE, R. (1995). Delineation of a slow-twitch-myofiber-specific transcriptional element by using in vivo somatic gene transfer. Proc. Natl. Acad. Sci. USA 92, 6185-6189.
20. CULIG, Z., HOBISCH, A., CRONAUER, M.V., RADMAYR, C., TRAPMAN, J., HITTMAIR, A., BARTSCH, G., and KLOCKER, H. (1994). Androgen receptoractivation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474-5478.
21. DACHS, G.U., and STRATFORD, I.J. (1996). The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br. J. Cancer 74, S126-S132.
22. DEUSCHLE, U., MEYER, W.K.-H., and THIESEN, H.-J. (1995). Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol. 15, 1907-1914.
23. DIMAIO, J.M., CLARY, B.M., VIA, D.F., COVENEY, E., PAPPAS, T.N., and LYERLY, H.K. (1994). Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 116, 205-213.
24. DZIENNIS, S., VAN ETTEN, R.A., PAHL, H.L., MORRIS, D.L., ROTHSTEIN, T.L., BLOSCH, C.M., PERLMUTTER, R.M., and TENEN, D.G. (1995). The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood 85, 319-329.
25. EFRAT, S., FUSCO-DEMANE, D., LEMBERG, H., EMRAN, O.A., and WANG, X. (1995). Conditional transformation of a pancreatic b-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. USA 92, 3576-3580.
26. EINERHAND, M.P.W., ANTONIOU, M., ZOLOTIKHIN, S., MUZYCZKA, N., BERNS, K.I., GROSVELD, F., and VALERIO, D. (1995). Regulated high-level human b-globin expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther. 2, 336-343.
27. FERRARI, G., SALVATORI, G., ROSSI, C., COSSU, G., and MAVILIO, F. (1995). A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum. Gene Ther. 6, 733-742.
28. FISHMAN, G.I., KAPLAN, M.L., and BUTTRICK, P.M. (1994). Tetracycline-regulated cardiac gene expression in vivo. J. Clin. Invest. 93, 1864-1868.
29. FORSS-PETTER, S., DANIELSON, P.E., CATSICAS, S., BATTENBERG, E., PRICE, J., NERENBERG, M., and SUTCLIFFE, J.G. (1990). Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 5, 187-197.
30. FURTH, P.A., ST. ONGE, L., BOGER, H., GRUSS, P., GOSSEN, M., KISTNER, A., BUJARD, H., and HENNIGHAUSEN, L. (1994). Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302-9306.
31. GAN, L., PERNEY, T.M., and KACZMAREK, L.K. (1996). Cloning and characterisation of the promoter for a potassium channel expressed in high frequency firing neurons. J. Biol. Chem. 271, 5859-5865.
32. GAZIT, G., KANE, S., NICHOLS, P., and LEE, A.S. (1995). Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res. 55, 1660-1663.
33. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
34. GOSSEN, M., and BUJARD, H. (1993). Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucleic Acids Res. 21, 4411-4412.
35. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MULLER, G., HILLEN, W., and BUJARD, H. (1995), Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
36. GREENBERG, D., MIAO, C.H., HO, W.-T., CHUNG, D.W., and DAVIE, E.W. (1995). Liver-specific expression of the human factor VII gene. Proc. Natl. Acad. Sci. USA 92, 12347-12351.
37. GUO, H., and KOHLHAW, G.B. (1996). Regulation of transcription in mammalian cells by yeast Leu3p and externally suppied inducer. FEBS Lett. 390, 191-195.
38. HALLAHAN, D.E., MAUCERI, H.J., SEUNG, L.P., DUNPHY, E.J., WAYNE, J.D., HANNA, N.N., TOLEDANO, A., HELLMAN, S., KUFE, D.W., and WEICHSELBAUM, R.R. (1995). Spatial and temporal control of gene therapy using ionising radiation. Nature Med. 1, 786-791.
39. HARATS, D., KURIHARA, H., BELLONI, P., OAKLEY, H., ZIOBER, A., ACKLEY, D., CAIN, G., KURIHARA, Y., LAWN, R., and SIGAL, E. (1995). Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin promoter. J. Clin. Invest. 95, 1335-1344.
40. HARSON, R., and GROSE, C. (1995). Egress of varicella-zoster virus from the melanoma cell; a tropism for the melanocyte. J. Virol. 69, 4994-5010.
41. HASHIMOTO, M., ARUGA, J., HOSOYA, Y., KANEGAE, Y., SAITO, I., and MIKOSHIBA, K. (1996). A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum. Gene Ther. 7, 149-158.
42. HAUCK, W., and STANNERS, C.P. (1995). Transcriptional regulation of the carcinoembryonic antigen gene. J. Biol. Chem. 270, 3602-3610.
43. HENNIG, G., LOWRICK, O., BIRCHMEIER, W., and BEHRENS, J. (1996). Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem. 271, 595-602.
44. HO, D.Y., MCLAUGHLIN, J.R., and SAPOLSKY, R.M. (1996). Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Mol. Brain Res. 41, 200-209.
45. HOFMANN, A., NOLAN, G.P., and BLAU, H.M. (1996). Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 93, 5185-5190.
46. HORVAI, A., PALINSKI, W., WU, H., MOULTON, K.S., KALLA, K., and GLASS, C.K. (1995). Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 92, 5391-5395.
47. HOUGLUM, K., BUCK, M., ALCORN, J., CONTRERAS, S., BORNSTEIN, P., and CHOJKIER, M. (1995). Two different cis-acting regulatory regions direct cell-specific transcription of the collagen α1 (I) gene in hepatic stellate cells and in skin and tendon fibroblasts. J. Clin. Invest. 96, 2269-2276.
48. HOWE, J.R., SKRYABIN, B.V., BELCHER, S.M., ZERILLO, C.A., and SCHMAUSS, C. (1995). The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol. Chem. 270, 14168-14174.
49. IDO, A., NAKATA, K., KATO, Y., NAKAO, K., MURATA, K., FUJITA, M., ISHII, N., TAMAOKI, T., SHIKU, H., and NAGATAKI, S. (1995). Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human a-fetoprotein gene promoter. Cancer Res. 55, 3105-3109.
50. IGARASHI, P., WHYTE, D.A., LI, K., and NAGAMI, G.T. (1996). Cloning and kidney cell-specific activity of the promoter of the murine renal Na-K-Cl cotransporter gene. J. Biol. Chem. 271, 9666-9674.
51. IIDA, A., CHEN, S.-T., FRIEDMANN, T., and YEE, J.-K. (1996). Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J. Virol. 70, 6054-6059.
52. IKEDA, E., ACHEN, M.G., BREIER, G., and RISAU, W. (1995). Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19761-19766.
53. JOKI, T., NAKAMURA, M., and OHNO, T. (1995). Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir. Hum. Gene Ther. 6, 1507-1513.
54. JUDDE, J.-G., SPANGLER, G., MAGRATH, I., and BHATIA, K. (1996). Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia. Hum. Gene Ther. 7, 647-653.
55. KALLMEIER, R.C., SOMASUNDARAM, C., and BABIJ, P. (1995). A novel smooth muscle-specific enhancer regulates transcription of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells. J. Biol. Chem. 270, 30949-30957.
56. KANAI, F., SHIRATORI, Y., YOSHIDA, Y., WAKIMOTO, H., HAMADA, H., KANEGAE, Y., SAITO, I., NAKABAYASHI, H., TAMAOKI, T., TANAKA, T., LAN, K.-H., KATO, N., SHIINA, S., and OMATA, M. (1996). Gene therapy for a-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex thymidine kinase gene. Hepatology 23, 1359-1368.
57. KANEKO, S., HALLENBECK, P., KOTANI, T., NAKABAYASHI, H., MCGARRITY, G., TAMAOKI, T., ANDERSON, W.F., and CHIANG, Y.L. (1995). Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res. 55, 5283-5287.
58. KIM, H.-J., GATZ, C., HILLEN, W., and JONES, T.R. (1995). Tetracycline repressor-regulated gene repression in recombinant human cytomegalovirus. J. Virol. 69, 2565-2573.
59. KOH, G.Y., KIM, S.-J., KLUG, M.G., PARK, K., SOONPAA, M.H., and FIELD, L.J. (1995). Targeted expression of transforming growth factor b1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J. Clin. Invest. 95, 114-121.
60. KOHNO, K., SATO, S.-I., TAKANO, H., MATSUO, K.-I., and KUWANO, M. (1989). The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Commun. 165, 1415-1421.
61. KREBS, C.J., MCAVOY, M.T., and KUMAR, G. (1995). The JC virus minimal core promoter is glial cell specific in vivo. J. Virol. 69, 2434-2442.
62. KUMAGAI, T., TANIO, Y., OSAKI, T., HORAI, T., and KISHIMOTO, T. (1995). Gene therapy for small cell lung cancer cells overexpressing myc family oncogenes by tumour-specific expression of the herpes simplex virus thymidine kinase gene. Gene Ther. 2, 33-41.
63. LEE, C.-H., LIU, M., SIE, K.-L., and LEE, M.-S. (1996). Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-a and topoisomerase IIa in prostate cancer. Anticancer Res. 16, 1805-1812.
64. LEE, J.-H., JANG, S.-I., YANG, J.-M., MARKOVA, N.G., and STEINERT, P.M. (1996). The proximal promoter of the human transglutaminase 3 gene. J. Biol. Chem. 271, 4561-4568.
65. LEE, K.-I., REDDY, E.P., and REDDY, C.D. (1995). Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumour virus promoter. J. Biol. Chem. 270, 24502-24508.
66. LEE, N.H., WEINSTOCK, K.G., KIRKNESS, E.F., EARLE-HUGHES, J.A., FULDNER, R.A., MARMAROS, S., GLODEK, A., GOCAYNE, J.D., ADAMS, M.D., KERLAVAGE, A.R., FRASER, C.M., and VENTER, J.C. (1995). Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proc. Natl. Acad. Sci. USA 92, 8303-8307.
67. LONG, F., and LINSENMAYER, T.F. (1995). Tissue-specific regulation of the type X collagen gene. J. Biol. Chem. 270, 31310-31314.
68. LU, B., and FEDEROFF, H.J. (1995). Herpes simplex virus type I amplicon vectors with glucocorticoid-inducible gene expression. Hum. Gene Ther. 6, 419-428.
69. MARKIEWICZ, S., BOSSELUT, R., LEDEIST, F., VILLARTAY, J.-P., HIVROZ, C., GHYSDAEL, J., FISCHER, A., and SAINT-BASILE, G. (1996). Tissue-specific activity of the γc chain promoter depends upon an Ets binding site and is regulated by GA-binding protein. J. Biol. Chem. 271, 14849-14855.
70. MAXWELL, I.H., SPITZER, A.L., LONG, C.J., and MAXWELL, F. (1996). Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters. Gene Ther. 3, 28-36.
71. MILLER, N., and VILE, R.G. (1995). Targeted vectors for gene therapy. FASEB J. 9, 190-199.
72. MILLER, N., VILE, R.G., and HART, I.R. (1995). Effects of modulators of tyrosinase activity on expression of mIL2 cDNA driven by the tyrosinase promoter. Melanoma Res. 5, 75-81.
73. MORISHITA, K., JOHNSON, D.E., and WILLIAMS, L.T. (1995). A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J. Biol. Chem. 270, 27948-27953.
74. NEERING, S.J., HARDY, S.F., MINAMOTO, D., SPRATT, S.K., and JORDAN, C.T. (1996). Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood, 88, 1147-1155.
75. NO, D., YAO, T.-P., and EVANS, R.M. (1996). Ecdysone-inducible expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93, 3346-3351.
76. OKUYAMA, T., HUBER, R.M., BOWLING, W., PEARLINE, R., KENNEDY, S.C., FLYE, M.W., and PONDER, K.P. (1996). Liver-directed gene therapy: A retroviral vector with a complete LTR and the ApoE enhancer-a1-antitrypsin promoter dramatically increases expression of human-a1-antitrypsin in vivo. Hum. Gene Ther. 7, 637-645.
77. OLSON, A.L., and PESSIN, J.E. (1995). Transcriptional regulation of the human GLUT4 gene promoter in diabetic transgenic mice. J. Biol. Chem. 270, 23491-23495.
78. OSAKI, T., TANIO, Y., TACHIBANA, I., HOSOE, S., KUMAGAI, T., KAWASE, I., OIKAWA, S., and KISHIMOTO, T. (1994). Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell-type specific expression of herpes simplex virus thymidine kinase gene. Cancer Res. 54, 5258-5261.
79. OZAKI, K., YOSHIDA, T., IDE, H., SAITO, I., IKEDA, Y., SUGIMURA, T., and TERADA, M. (1996). Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC. Hum. Gene Ther. 7, 1483-1490.
80. PASSMAN, R.S., and FISHMAN, G.I. (1994). Regulated expression of foreign enes in vivo after germline transfer. J. Clin. Invest. 94, 2421-2425.
81. PAULUS, W., BAUR, I., BOYCE, F.M., BREAKEFIELD, X.O., and REEVES, S.A. (1996). Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70, 62-67.
82. PERROS, M., DELEU, L., VANACKER, J.-M., KHERROUCHE, Z., SPRUYT, N., FAISST S., and ROMMELAERE, J. (1995). Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells. J. Virol. 69, 5506-5515.
83. RAMIREZ, A., VIDAL, M., BRAVO, A., LARCHER, F., and JORCANO, J.L. (1995). A 5′-upstream region of a bovine keratin 6 gene confers tissue-specific expression and hyperproliferation-related induction in transgenic mice. Proc. Natl. Acad. Sci. USA 92, 4783-4787.
84. RICHARDS, C.A., AUSTIN, E.A., and HUBER, B.E. (1995). Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther. 6, 881-893.
85. RIVERA, V.M., CLACKSON, T., NATESAN, S., POLLOCK, R., AMARA, J.F., KEENAN, T., MAGARI, S.R., PHILLIPS, T., COURAGE, N.L., CERASOLI, F., HOLT, D.A., and GILMAN, M. (1996). A humanised system for pharmacologic control of gene expression. Nature Med. 2, 1028-1032.
86. ROBINSON, D., ELLIOTT, J.F., and CHANG, L.-J. (1995). Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat. Gene Ther. 2, 269-278.
87. ROEMER, K., JOHNSON, P.A., and FRIEDMANN, T. (1995). Transduction of foreign regulatory sequences by a replication-defective herpes simplex virus type 1: The rat neuron-specific enolase promoter. Virus Res. 35, 81-89.
88. SADELAIN, M., WANG, C.H.J., ANTONIOU, M., GROSVELD, F., and MULLIGAN, R.C. (1995). Generation of a high titer retroviral vector capable of expressing high levels of the human b-globin gene. Proc. Natl. Acad. Sci. USA 92, 6728-6732.
89. SCHOCH, S., CIBELLI, G., and THIEL, G. (1996). Neuron-specific gene expression of synapsin I. J. Biol. Chem. 271, 3317-3323.
90. SCHULTZE, N., BURKI, Y., LANG, Y., CERTA, U., and BLUETHMANN, H. (1996). Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nature Biotechnol. 14, 499-503.
91. SHIMIZU, R.T., BLANK, R.S., JERVIS, R., LAWRENZ-SMITH, S.C., and OWENS, G.K. (1995). The smooth muscle a-actin gene promoter is differentially regulated in smooth muscle versus nonsmooth muscle cells. J. Biol. Chem. 270, 7631-7643.
92. SHOCKETT, P., DIFILIPPANTONIO, M., HELLMAN, N., and SCHATZ, D.G. (1995). A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6522-6526.
93. SMITH, J.D., WONG, E., and GINSBERG, M. (1995). Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice. Proc. Natl. Acad. Sci. USA 92, 11926-11930.
94. SONCINI, M., YET, S.-F., MOON, Y., CHUN, J.-Y., and SUL, H.S. (1995). Hormonal and nutritional control of the fatty acid synthase promoter in transgenic mice. J. Biol. Chem. 270, 30339-30343.
95. SU, H., CHANG, J.C., XU, S.M., and KAN, Y.W. (1996). Selective killing of AFP-positive heptocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene. Hum. Gene Ther. 7, 463-470.
96. TAMAI, K., SILOS, S.A., LI, K., KORKEELA, E., ISHIKAWA, H., and UITTO, J. (1995). Tissue-specific expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1). J. Biol. Chem. 270, 7609-7614.
97. UETSUKI, T., TAKAGI, K., SUGIURA, H., and YOSHIKAWA, K. (1996). Structure and expression of the mouse necdin gene. J. Biol. Chem. 271, 918-924.
98. VARLEY, A.W., COULTHARD, M.G., MEIDELL, R.S., GERARD, R.D., and MUNFORD, R.S. (1995). Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc. Natl. Acad. Sci. USA 92, 5346-5350.
99. VILE, R.G., DIAZ, R.M., MILLER, N., MITCHELL, S., and RUSSELL, S.J. (1995). Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter. Virology 214, 307-313.
100. WANG, X.-S., YODER, M.C., ZHOU, S.Z., and SRIVASTAVA, A. (1995). Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic cells. Proc. Natl. Acad. Sci. USA 92, 12416-12420.
101. WANG, Y., O'MALLEY, B.W., TSAI, S.Y., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91, 8180-8184.
102. WARD, G.A., STOVER, C.K., MOSS, B., and FUERST, T.R. (1995). Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc. Natl. Acad. Sci. USA 92, 6773-6777.
103. WEICHSELBAUM, R.R., HALLAHAN, D.E., BECKETT, M.A., MAUCERI, H.J., LEE, H., SUKHATME, V.P., and KUFE, D.W. (1994). Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res. 54, 4266-4269.
104. WHELAN, J., and MILLER, N. (1996). Generation of estrogen receptor mutants with altered ligand specificity for use in establishing a regulatable gene expression system. J. Steroid Biochem. Mol. Biol. 58,3-12.
105. WOOD, I.C., ROOPRA, A., HARRINGTON, C., and BUCKLEY, N.J. (1995). Structure of the m4 cholinergic muscarinic receptor gene and its promoter. J. Biol. Chem. 270, 30933-30940.
106. WU, H., MAHATA, S., MAHATA, M., WEBSTER, N.J.G., PARMER, R.J., and O'CONNOR, D.T. (1995). A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A. J. Clin. Invest. 96, 568-578.
107. ZHOU, D., CLARKE, P., WANG, J., and CHEN, S. (1996). Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells. J. Biol. Chem. 271, 15194-15202.
108. ZHOU, S.Z., LI, Q., STAMATOYANNOPOULOS, G., and SRIVASTAVA, A. (1996). Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a human β-globin gene. Gene Ther. 3, 223-229.